Cita APA

Pal, S. K., Rosenberg, J. E., Hoffman-Censits, J. H., Berger, R., Quinn, D. I., Galsky, M. D., . . . Bajorin, D. F. (2018). Efficacy of BGJ398, a fibroblast growth factor receptor 1–3 inhibitor, in patients with previously treated advanced urothelial carcinoma with FGFR3 alterations. Cancer Discov.

Chicago Style Citation

Pal, Sumanta K., et al. "Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1–3 Inhibitor, in Patients With Previously Treated Advanced Urothelial Carcinoma With FGFR3 Alterations." Cancer Discov 2018.

Cita MLA

Pal, Sumanta K., et al. "Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1–3 Inhibitor, in Patients With Previously Treated Advanced Urothelial Carcinoma With FGFR3 Alterations." Cancer Discov 2018.